Surfactant given with a thin tube or catheter device
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests two ways of giving surfactant (a lung medicine) to very premature babies with respiratory distress syndrome. It may help show which method works better and is safer for helping newborn lungs breathe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 32 weeks of pregnancy
- Your baby is on CPAP for breathing support
- Doctors have diagnosed respiratory distress syndrome (RDS) based on signs and chest X-ray
- Your baby needs surfactant treatment
- Your baby should not need surfactant as part of immediate delivery-room resuscitation
- Your baby does not have certain birth conditions that affect breathing (like a heart or airway connection problem)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a less invasive way to give surfactant (a lung treatment) to babies born a few weeks early who need breathing help. It aims to see if this method works as well as standard care.
This study compares two methods—video laryngoscopy and direct laryngoscopy—to give surfactant (a medicine that helps babies' lungs work better) to very premature infants. It aims to find which method is safer and easier for babies born at 28 weeks or earlier who need surfactant within the first 36 hours after birth.
This study looks at different ways doctors give a life-saving medication called surfactant to premature babies who are struggling to breathe. Researchers want to understand which delivery methods work best and help improve care.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This study compares two ways of giving surfactant (a lung-coating medicine) to newborns with breathing trouble: LISA (a gentler, less invasive method) versus traditional breathing tube delivery. Researchers will use ultrasound to see how the medicine spreads in each baby's lungs to find the best approach.
This study compares two ways of giving surfactant (a natural substance that helps lungs stay open) to premature babies who need extra breathing support. It aims to find which method works better and is safer for infants born at 29 to 36 weeks.
Hear when a new RDS of Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.